The research

The programs that we cofinance

Since the creation of the association in 2011, we have allocated MORE THAN 12 MILLION EUROS to 29 French and European research programs to accelerate research against childhood cancer.

Our strategy consists of funding fundamental and translational research programs to better understand the causes of childhood cancer and resistance to treatments, as well as early phase clinical trials that allow children who suffer relapse or therapeutic failure to benefit from innovative personalized treatments, thanks to precision medicine.

Since 2012, the programs that we have co-funded have come from recommendations from experts in pediatric oncology: the European consortium ITCC *, the SFCE ** and, since 2020, the scientific committee of Fight Kids Cancer.

* Innovative Therapies for Children with Cancer
** Société Française de lutte contre les Cancers et leucémies de l’Enfant et de l’adolescent

BETTER UNDERSTAND

It means finding the “weakness” of the tumor in order to target the best possible treatment, by analyzing the complete sequencing of tumors or leukemia. It also consists in analyzing all the available data in order to better understand childhood cancer.

BETTER CURE

It means proposing better adapted, better targeted and therefore more effective therapies. Some of the programs that we finance offer treatments that are particularly innovative, such as immunotherapy.

RESEARCH AGAINST CHILDHOOD CANCER: ADVANCES IN 2020

Research against childhood cancer that we fund: four major advances in 2020   With the launch of our first Fight Kids Cancer call for projects, with the Belgian Kick Cancer Foundation…

Find out more >

Fight Kids Cancer : six selected pediatric cancer research programs

Following the innovative Fight Kids Cancer call for projects that we launched in January 2020 with the Belgian KickCancer Foundation and the Luxembourg Kriibskrank Kanner Foundation, twenty-three research projects against…

Find out more >

SELUDEX trial

EVALUATION OF A NEW TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA, THE MOST COMMON PEDIATRIC CANCER This trial was co-funded by the Children Without Cancer City 2018 race.       SELUDEX…

Find out more >
Read all articles

Conventions and conferences

Conventions and conferences

Conventions and conferences

Understand, analyze, testify, exchange, propose, enlist: being on all the fronts to defend our cause and accelerate the decision process and the action in favor of research. Since the creation of the association, we participate in the main conventions and conferences on pediatric cancers in France and internationally.
Find out more

Enlist the research stakeholders

Enlist the research stakeholders

Enlist the research stakeholders

Beyond the financial assistance that we bring to the researchers, we enlist and unite the research stakeholders in France and Europe so that childhood cancer becomes a priority for all.
Every year in February, we organize a seminar at the French Senate to bring together the research players in France. In 2021, the Seminar will be virtual.
MAR
06

8th edition e-Seminar

06 March 2021
Find out more
March 2018 : Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE
March 2018 – 10-year report on the European Paediatric Regulation and its impact on new drugs for children’s cancers

Publications

Patricia Blanc, President of Imagine for Margo, has been the co-author of several reference publications on childhood cancers.

Find out more

Our scientific partners

ITCC
SFCE
Gustave Roussy
Institut Curie

Words that move us

“The Imagine for Margo association has helped place childhood cancer on the European agenda. Thanks to Imagine for Margo, we are gaining time and we are implementing tests that would not have started for lack of funding.”

Professor Gilles VASSAL, Director of Research at Gustave Roussy

“I would like to thank you for bringing us together again and again for this cause and to remind us what we are striving for. Because at the end, it's the patients that we want to help and in this sense your support is very helpful."

Dr. Stefan Pfister, Chair of the Biology Committee at ITCC

“Imagine for Margo provides huge support in backing our projects financially, in a significant and constant manner. This allows us to move forward faster in our research”

Birgit Geoerger, researcher at Gustave Roussy, director of the MAPPYACTS and ESMART programs

“The work that the association does to bring together, at the same time, researchers, clinicians, laboratories, pharmaceuticals, the families, is really something extremely important. The financial help is of course very important, but what Imagine for Margo brings goes beyond that.”

Gudrun Schleiermacher, researcher at the Curie Institute, director of the MICCHADO program